Deletion analysis and alternative splicing define a transactivation inhibitory domain in human oncoprotein REL - Wikidata - awgldk - TriplyDB

Deletion analysis and alternative splicing define a transactivation inhibitory domain in human oncoprotein REL

Deletion analysis and alternative splicing define a transactivation inhibitory domain in human oncoprotein REL

http://www.wikidata.org/entity/Q33706844

about

c-Rel and its many roles in cancer: an old story with new twists Two alleles of NF-kappaB in the sea anemone Nematostella vectensis are widely dispersed in nature and encode proteins with distinct activities Identification of an NF-κB p50/p65-responsive site in the human MIR155HG promoter.Overexpression of an activated REL mutant enhances the transformed state of the human B-lymphoma BJAB cell line and alters its gene expression profile Ser484 and Ser494 in REL are the major sites of IKK phosphorylation in vitro: evidence that IKK does not directly enhance GAL4-REL transactivation.NF-kappaB down-regulates expression of the B-lymphoma marker CD10 through a miR-155/PU.1 pathway.Characterization of the core elements of the NF-κB signaling pathway of the sea anemone Nematostella vectensis.The c-Rel Transcription Factor in Development and Disease.Alternative splicing in the NF-kappaB signaling pathway.A haplotype variant of the human chromogranin A gene (CHGA) promoter increases CHGA expression and the risk for cardiometabolic disorders.

P2860

Q26772234-73B09063-5DBA-409D-8972-1AA55E3F6FEF Q27340174-DA9330CB-5A25-41FE-B59C-4418F86B5CBB Q31140009-FC45081A-1E87-4A60-8A3D-764E52E948F0 Q33551720-B1901855-9851-4A12-ADDE-BD271485D0DC Q33658906-10AB15FF-B5AE-4347-AC33-5BD3C87B6C6F Q34143653-2C490A45-81BD-4B17-ABD4-31388C8CDBD5 Q34742275-6700E6C2-8DE0-4A60-A51A-A3900CE75999 Q35556506-259267AF-A429-4DEF-8287-5B47F247E4C4 Q37057998-4260748E-1DDC-4D33-9EA9-85401C54C4E1 Q42511816-EF2D84E2-28D9-4FD7-B7C7-64B4CD93EC16

P2860

Deletion analysis and alternative splicing define a transactivation inhibitory domain in human oncoprotein REL

http://www.wikidata.org/entity/Q33706844

description

2008 nî lūn-bûn

@nan

2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Deletion analysis and alternat ...... omain in human oncoprotein REL

@ast

Deletion analysis and alternat ...... omain in human oncoprotein REL

@en

type

label

Deletion analysis and alternat ...... omain in human oncoprotein REL

@ast

Deletion analysis and alternat ...... omain in human oncoprotein REL

@en

prefLabel

Deletion analysis and alternat ...... omain in human oncoprotein REL

@ast

Deletion analysis and alternat ...... omain in human oncoprotein REL

@en

P1433

Q33706844-33ECB0CC-912B-4E9E-86CD-15E88E798772

P1476

Q33706844-22F3E2D8-F9D1-49FD-BD31-8B57A664AAA9

P2093

Q33706844-36D19DB1-97EB-4C6C-A81F-8921F2255127

Q33706844-B21521ED-246D-422D-B879-0E7D17EB87FB

Q33706844-BEB72454-684E-4C8E-A1CB-0894DADF1416

Q33706844-EC45221E-6115-43BF-848D-D9DE97081C1A

P2860

Q33706844-1097AB80-AF5D-4775-9F33-A4E5382235CB

Q33706844-1179114A-96CE-431B-84E1-AC33C1068E3A

Q33706844-1962856A-F6C1-45E7-986F-38C9380DA2C2

Q33706844-29BEF466-629F-4BBE-BA1C-7FA3806433EF

Q33706844-4BDE7878-731B-4D87-946D-D997642E6BFB

Q33706844-530768EF-62B5-4501-926E-1F2868B11F2B

Q33706844-541059DA-6281-47E3-8B0B-9DD829EEB3B1

Q33706844-68532708-393F-4760-A606-E53CE727F7A7

Q33706844-6A5F95B6-6CBC-4D0C-A39F-C89BA7CE67FE

Q33706844-6C026F14-2E8A-4AC0-A969-D0F745075276

P2888

Q33706844-6C68EBFE-D48F-4ACF-A86D-2916C14D8BA9

P304

Q33706844-81B709D2-54D4-49BD-98C5-273282A74FFD

P31

Q33706844-6C9A0FAB-FF92-46A1-BB07-5CB8B4096D10

P356

Q33706844-16671F97-6EE4-4BB9-9DC8-B2AA01EDD98A

P407

Q33706844-D85DB7EE-452A-4821-8994-359FF92715E1

P433

Q33706844-6E4A3BE2-C002-447F-BB01-E1AB95FC998E

P478

Q33706844-FF920466-B656-4D23-9B48-CD117D9CF1B6

P577

Q33706844-B0833326-C659-4B86-9B92-89B2F02F3598

P5875

Q33706844-926B3B09-83BB-4EEE-B502-077881F6BF4D

P6179

Q33706844-6098AC94-1B83-4FD5-AB86-87C097F91F74

P698

Q33706844-05B3BF84-6D22-440B-9563-05AD0CBBEC79

P932

Q33706844-7CAFB531-27B7-4759-BEF1-48E343701575

P356

P1433

P1476

Deletion analysis and alternat ...... omain in human oncoprotein REL

@en

P2093

J R Leeman

http://www.w3.org/2001/XMLSchema#string

M A Weniger

http://www.w3.org/2001/XMLSchema#string

T D Gilmore

http://www.w3.org/2001/XMLSchema#string

T F Barth

http://www.w3.org/2001/XMLSchema#string

P2860

The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1

p53 isoforms can regulate p53 transcriptional activity.

X-ray crystal structure of proto-oncogene product c-Rel bound to the CD28 response element of IL-2

The c-Rel transcription factor and B-cell proliferation: a deal with the devil

A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon

Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300

Shared principles in NF-kappaB signaling

Function of alternative splicing.

Defects in pre-mRNA processing as causes of and predisposition to diseases.

Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis

P2888

P304

6770-6781

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ONC.2008.284

http://www.w3.org/2001/XMLSchema#string

P407

P433

53

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P577

2008-08-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23164275

http://www.w3.org/2001/XMLSchema#string

P6179

1006898197

http://www.w3.org/2001/XMLSchema#string

P698

18695674

http://www.w3.org/2001/XMLSchema#string

P932

2832920

http://www.w3.org/2001/XMLSchema#string